![Douglas Jermasek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Jermasek
Corporate Officer/Principal bei
UNICYCIVE THERAPEUTICS, INC.
Vermögen: 129 150 $ am 31.05.2026
Profil
Douglas Jermasek currently works at Unicycive Therapeutics, Inc., as Executive Vice President-Corporate Strategy from 2021.
Mr. Jermasek also formerly worked at Deltanoid Pharmaceuticals, Inc., as Chief Executive Officer, Keryx Biopharmaceuticals, Inc., as Vice President-Marketing & Strategy from 2016 to 2018, Genzyme Corp., as Senior Vice President & General Manager, and Akebia Therapeutics, Inc., as Senior Vice President-Marketing & Strategy.
Mr. Jermasek received his undergraduate degree from Brigham Young University and Masters Business Admin degree from BYU Marriott School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 17’500 ( 0.07% ) | 129 150 $ | 31.05.2026 |
Aktive Positionen von Douglas Jermasek
| Unternehmen | Position | Beginn |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2021 |
Ehemalige bekannte Positionen von Douglas Jermasek
| Unternehmen | Position | Ende |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Vertrieb & Marketing | 12.12.2018 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| AKEBIA THERAPEUTICS, INC. | Vertrieb & Marketing | - |
Deltanoid Pharmaceuticals, Inc.
 Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops therapies for the treatment of human diseases | Vorstandsvorsitzender | - |
Ausbildung von Douglas Jermasek
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deltanoid Pharmaceuticals, Inc.
Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops therapies for the treatment of human diseases | Commercial Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
BYU Marriott School
 BYU Marriott School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unicycive Therapeutics, Inc.
 Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
